Consolidated Biosciences ApS: Financial statements 2020
CVR: 40180230
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Consolidated Biosciences ApS (CVR 40180230) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -43,000 and a net result of DKK -584,728 compared with DKK -429,852 the year before. Equity in the 2020 report amounted to DKK 65,420. The solvency ratio was 0.2%.
- Gross Profit
- DKK -43,000
- Profit/Loss
- DKK -584,728
- Equity
- DKK 65,420
- Total Assets
- DKK 38,217,101
Official annual report
How creditworthy is Consolidated Biosciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Consolidated Biosciences ApS has published its annual report for 2019. Gross profit came to DKK -24,656, and the net result was DKK -429,852.
About Consolidated Biosciences ApS
Consolidated Biosciences ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2019. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Lone Schøtt Kunøe. The company is owned by CENTRAL EUROPEAN FOOD PRODUCTION COMPANY ApS, CONSOLIDATED HOLDINGS A/S and L1 HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,501 and a net result of DKK -1,814,488 compared with DKK -1,740,301 the year before. Equity in the 2025 report amounted to DKK 202,862.